Top News

Statement | April 23, 2019
WASHINGTON, D.C. – Scott Whitaker, president and CEO of the Advanced Medical Technology Association (AdvaMed), issued the following statement on CMS’s FY 2020 Inpatient Prospective Payment System proposed rule: 
Press Release | April 19, 2019
Press Release | April 10, 2019
WASHINGTON, D.C. – Scott Whitaker, president and CEO of the Advanced Medical Technology Association (AdvaMed), issued the following statement on introduction of bipartisan legislation (H.R. 2207) in the U.S. House of Representatives to permanently repeal the medical device excise tax:


May 13, 2019 to May 14, 2019
| Irvine, CA
Click here for the agenda FDA and industry experts are coming together to teach you the basics of 510(k) submissions. This unique opportunity will help you better understand the FDA perspective on... Read More
May 14, 2019 to May 15, 2019
| Paris, France
As of 2019, the Global MedTech Conference (GMTCC) will be included in the MedTech Forum. Organised jointly by MedTech Europe and AdvaMed for over a decade, the Global MedTech Compliance Conference (... Read More
May 15, 2019 | Irvine, CA
Click here to view the agenda During this interactive workshop, FDA and industry experts will lead you through the regulatory and practical guidelines governing when an investigational device... Read More
May 16, 2019 to May 17, 2019
| Irvine, CA
Click here to view the agenda Completing the set of interactive submissions workshops, industry and FDA experts will lead you through the strategic considerations and practical steps of filing a... Read More
May 22, 2019 to May 23, 2019

Industry News

Toronto, CA -- Perimeter Medical Imaging, Inc. (“Perimeter Medical”) announced today that the company received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the second generation of their platform imaging tool used in the evaluation of human tissue microstructure by providing two-dimensional, cross-sectional, real-time depth visualization. Enhancements to the newly cleared OTIS™ 2.0 system over the previous generation include:  A novel specimen positioning...
CAMPBELL, Calif. -- Tioga Medical, a newly formed Shifamed portfolio company, announced today the closing of its Series A preferred stock financing, raising a total of $15M. Tioga Medical was founded to provide physicians and patients with an elegant transcatheter valve replacement experience that is procedurally simpler and less invasive than current mitral or tricuspid approaches, many of which require transapical access, intricate device sizing regimens, and/or excessive bulk in the...
Dthera™ Sciences (OTCQB: DTHR), a leading digital therapeutic company specialized in neurodegenerative diseases, is pleased to announce that it has entered into an exclusivity agreement with a company headquartered in Japan for development and commercialization rights to Dthera's lead product, DTHR-ALZ. The exclusivity agreement provides exclusive rights to the Japanese partner to perform feasibility studies in Japan and to negotiate a licensing agreement or other transaction for the Japanese...
Royal Philips has unveiled a new mixed reality concept to aid in minimally invasive surgeries, which it has developed with Microsoft, at the MWC 2019 mobile technology conference in Barcelona, Spain.
Digital Journal
SAN DIEGO, CA - iAssay® Inc., a privately held developer of the world's first open platform, point of care (POC) reader for remote medical diagnostics, announced today that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for U.S. Patent Application 13/074,209. The allowed patent includes 66 claims relating to multiple types of patient tests, wireless communications, plug-in modules, and user guides. The patent application is expected to issue in mid-2019...

Twitter Feed

April 24, 2019 - 3:01pm
For Wendy, the benefits of keeping her hair during chemo go well beyond mere aesthetics. Read her story.
April 24, 2019 - 1:02pm
Congress’ choice should be simple: Repeal the medical device tax for good. Read more from .